Nader said in a CC a couple of months ago that there is Leronlimab from the beginnings of their HIV-1 trials still in cold storage that still shows efficacy/strength. He also said that CytoDyn continues to work with the FDA with arriving at a shelf-life for commercial Leronlimab.

Deep storage life would be a HUGE plus for stockpiling.